Form 8-K - Current report:
SEC Accession No. 0001493152-26-019133
Filing Date
2026-04-27
Accepted
2026-04-27 16:10:27
Documents
12
Period of Report
2026-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44142
  Complete submission text file 0001493152-26-019133.txt   258259

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20260427.xsd EX-101.SCH 3870
3 XBRL DEFINITION FILE cdt-20260427_def.xml EX-101.DEF 26769
4 XBRL LABEL FILE cdt-20260427_lab.xml EX-101.LAB 37006
5 XBRL PRESENTATION FILE cdt-20260427_pre.xml EX-101.PRE 25393
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5665
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 26900993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)